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Abstract 
Background: The aetiology of most childhood cancers is largely unknown. Spatially varying environmental factors 
such as traffic-related air pollution, background radiation and agricultural pesticides might contribute to the develop-
ment of childhood cancer. This study is the first investigation of the spatial disease mapping of childhood cancers 
using exact geocodes of place of residence.
Methods: We included 5947 children diagnosed with cancer in Switzerland during 1985–2015 at 0–15 years of age 
from the Swiss Childhood Cancer Registry. We modelled cancer risk using log-Gaussian Cox processes and indirect 
standardisation to adjust for age and year of diagnosis. We examined whether the spatial variation of risk can be 
explained by modelled ambient air concentration of  NO2, modelled exposure to background ionising radiation, area-
based socio-economic position (SEP), linguistic region, duration in years of general cancer registration in the canton 
or degree of urbanisation.
Results: For all childhood cancers combined, the posterior median relative risk (RR), compared to the national level, 
varied by location from 0.83 to 1.13 (min to max). Corresponding ranges were 0.96 to 1.09 for leukaemia, 0.90 to 1.13 
for lymphoma, and 0.82 to 1.23 for central nervous system (CNS) tumours. The covariates considered explained 72% of 
the observed spatial variation for all cancers, 81% for leukaemia, 82% for lymphoma and 64% for CNS tumours. There 
was weak evidence of an association of CNS tumour incidence with modelled exposure to background ionising radia-
tion (RR per SD difference 1.17; 0.98–1.40) and with SEP (1.6; 1.00–1.13).
Conclusion: Of the investigated diagnostic groups, childhood CNS tumours showed the largest spatial variation. The 
selected covariates only partially explained the observed variation of CNS tumours suggesting that other environ-
mental factors also play a role.
Keywords: Cancer clusters, Central nervous system cancer, Childhood cancer, Bayesian spatial modelling, Point 
processes
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
The causes of childhood cancers are poorly understood. 
Epidemiological research on the atomic bomb survivors 
indicated that ionising radiation in high doses can cause 
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childhood leukaemia and central nervous system (CNS) 
tumours [1, 2]. A number of environmental factors have 
been suggested that could partially explain cancer risks in 
the general population, including traffic-related air pollu-
tion [3], background radiation [2, 4] and agricultural pes-
ticides [5]. These risk factors vary in space and it is thus 
natural to expect spatial variation in childhood cancer 
incidence. Conversely, investigating the spatial variation 
of childhood cancer incidence might help generate new 
hypotheses about environmental risk and identify areas 
of potential environmental contamination.
Disease mapping is a common way of capturing the 
spatial variation of a disease. Direct estimation of dis-
ease incidence in small areas is subject to large sampling 
variability, particularly for rare diseases. Disease mapping 
mitigates this problem by exploiting spatial correlation 
between neighbouring areas and smoothing small area 
rates based on neighbouring values [6]. Several previous 
studies have investigated spatial variation in childhood 
cancer risk using disease mapping. Studies focusing on 
childhood leukaemia reported evidence of spatial varia-
tion in Ohio, USA [7], Texas, USA [8], Yorkshire, UK [9], 
but not in France [10]. The study in Texas also examined 
childhood lymphomas and reported some evidence of 
spatial variation of Hodgkin lymphoma [8]. A study in 
Kenya reported evidence of spatial variation of Burkitt’s 
lymphoma with higher rates in the northern part of the 
country [11]. A study in Florida, USA, focusing on child-
hood brain tumours reported some evidence of high 
excess risk in several non-adjacent counties [12].
The different findings regarding spatial variation of 
childhood cancers might reflect differences between the 
countries or methodological limitations. Most previous 
studies relied on areal data (data aggregated on admin-
istrative units) [8–10, 12–14]. Results from such studies 
depend on spatial unit selected, which is referred to as 
the Modifiable Areal Unit Problem [15]. Furthermore, 
associations between cancer incidence and environ-
mental factors assessed at group level may be subject 
to ecological fallacy, i.e. they may not correctly reflect 
underlying associations at the individual level [16]. In a 
simulation study, we showed that spatial modelling based 
on exact geocodes is more accurately identifies areas of 
higher risk compared to traditional disease mapping 
based on count data aggregated to small administrative 
areas [17]. To the best of our knowledge, only one pre-
vious study used precise geocodes, but the authors did 
not attempt to explain the observed variation of child-
hood leukaemia risk by incorporating environmental 
exposures in the model [7]. Lastly, all the previous studies 
used geographical information about the place of diagno-
sis of the cancer cases. Children may be more susceptible 
to certain environmental exposures early in life and thus 
location of residence at birth may be more relevant [18].
In this nationwide study, we investigated the spatial 
variation of childhood cancers in Switzerland using pre-
cise locations of residence. We performed analysis using 
place of birth and diagnosis. We focused on the following 
main diagnostic groups: all childhood cancers, childhood 
leukaemia, lymphoma and CNS tumours and assessed 
the extent to which selected covariates could explain the 
observed spatial variation.
Methods
Study population
We retrieved children diagnosed with cancer in Swit-
zerland during 1985–2015 at age 0–15 from the Swiss 
Childhood Cancer Registry (SCCR). SCCR is a nation-
wide registry with high completeness. Estimates suggest 
that it includes 91% of all incident cases for the period 
1985–2009 and > 95% for 1995–2009 [19]. It collects resi-
dential addresses from time of diagnosis back to birth. 
The addresses were geocoded according to the Swiss 
grid coordinate system using a combination of different 
sources of georeferenced building addresses including 
the Swiss postal system, the geoportal maintained by the 
Federal Office of Topography (swisstopo; http://map.geo.
admin .ch), and Google Maps. We wrote an R function to 
assign a pair of geocodes to every address (https ://githu 
b.com/gkons tanti noudi s/GeoSw iss) based on these data 
sources. Geocodes that could not be identified by this 
procedure where manually searched using the mentioned 
web sites. If the available address information was incom-
plete (e.g. only street without number, or only postal code 
without street), approximated geocodes were assigned 
(e.g. a central location on the street, or of the municipal-
ity). We classified cases based on the margin of error 1 
(< 50 m), 2 (> 50 m and < 100 m), 3 (> 100 m and < 500 m) 
and 4 (> 500 m). For 94% of the cases, we geocoded resi-
dential addresses with a margin of error < 100 m.
Population data was available through the Swiss 
National Cohort (SNC) which includes exact geocoded 
residential locations of all Swiss residents at the times of 
censuses (1990, 2000 and 2010–2015). To calculate popu-
lation at risk by age group, year and spatial unit (1  km2 
grid cell or municipality), we performed linear interpo-
lation of age, year and spatial unit specific weights, see 
Additional file 1: Text S1 and Figures S1, S2. The 1  km2 
grid size was selected as a compromise between our goal 
of high precision maps on the one hand, and data con-
fidentiality considerations and reduction of computa-
tional burden on the other. We then performed indirect 
standardisation by calculating the expected number of 
cases adjusted by age and year: Let qi,j be the nationwide 
cancer incidence rate and Pi,j,k the population counts 
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with subscript referring to the i-th age group (0–4, 5–9, 
10–15), j-th year (1985–2015), and k-th spatial unit (grid 
cell, or municipality). Then the expected number of cases 
in the k-th spatial unit is:
To calculate the expected number of cases for the anal-
ysis based on the location at birth we used a similar pro-
cedure restricting to children aged < 1 year at census:
where the age index i = 0 represents children aged < 1 
year. We repeated the aforementioned procedures for the 
different diagnostic groups. For more information refer 
to Additional file 1: Text S1.
Outcomes
The SCCR classifies diagnoses according to the Interna-
tional Classification of Childhood Cancers Third Edition 
(ICCC3). We examined all childhood cancers combined 
(ICCC3 main groups I–XII) and then separately child-
hood leukaemia (ICCC3 main group I), lymphoma 
(ICCC3 main group II) and CNS tumours (ICCC3 main 
group III). We focused on the main diagnostic groups 
because of the larger sample size.
Covariates
As potential explanatory variables, we included pre-
dicted ambient air concentration of  NO2, predicted total 
dose rate from terrestrial gamma and cosmic radiation, 
neighbourhood-level socio-economic position (Swiss-
SEP for the year 2001) [20], years of general cancer reg-
istration in the canton, language region and the degree 
of urbanisation as covariates (Additional file 1: Table S1 
and Figures S3–S8). Traffic-related air pollution and total 
background radiation were previously found to be asso-
ciated with childhood cancer risks in Switzerland [21, 
22]. We included SEP, linguistic region and degree of 
urbanisation to account for regional, socio-economic and 
socio-cultural differences. We included years of cantonal 
cancer registration to account for heterogeneous registry 
completeness. The SCCR records childhood cancer cases 
treated in one of the nine specialised paediatric oncol-
ogy (SPOG) clinics and complements the registry with 
any additional cases recorded by the cantonal registries. 
Some cantons already had a cancer registry at the begin-
ning of our study period, others established one during 
the study period and others after the end of the study. For 
cantons with more years of general registration, we thus 
Ek =
∑
i
∑
j
qi,j · Pi,j,k .
Ek =
∑
j
q0,j · P0,j,k ,
expect the “apparent” childhood cancer incidence over 
the study period to be slightly higher.
Statistical analysis
We used log-Gaussian Cox processes (LGCPs) to model 
locations of incident cancer cases [23]. The point pro-
cess assumed to generate the case locations is an inho-
mogeneous Poisson process with random intensity 
e(s)r(s) , s ∈W  , where e(s) denotes the intensity of the 
expected number of cases (approximated with Ek ), r(s) 
the risk and W  denotes the observation window (Swit-
zerland in our case). We model the continuous log-
risk surface log r(s), s ∈W  , via a spatial mixed effects 
model X(s)β + Z(s) , where the first summand adjusts 
for covariate effects and the second summand models 
the spatial variation. The process Z(s) is assumed to be 
a zero mean Gaussian random field (GRF) with Matérn 
covariance function. We fix the smoothness parameter ν 
to 1, which is common practice to alleviate the computa-
tional burden [24]. The Gaussian field is then controlled 
by two parameters: a variance parameter σ 2 and a range 
parameter ρ(roughly, the distance between s and t in W  
at which the correlation between the values Z(s) and 
Z(t) of the field falls below 0.10). To be avoid large dense 
covariance matrices, we use the approach by Lindgren 
et al. [25]. Thus, we approximate the field Z(s) , s ∈W  , by 
a finite element representation of the (weak) solution of 
a certain stochastic partial differential equation (SPDE):
where M denotes the total number of nodes in an under-
lying triangulation of W  , ψi are piecewise linear basis 
functions taking the value 1 at the i-th node and 0 at 
every other node, and Zi are random weights forming a 
(finitely indexed) Gaussian Markov random field (GMRF) 
Z = (Zi)i=1,...,M . The latter has a sparse precision matrix 
Q(ρ, σ) . We used penalised complexity priors (PC priors) 
for the hyperparameters σ and ρ . For the construction of 
these priors in the present GRF setting, see [26]. The full 
model specification then reads:
Z(s) ≈
M∑
i=1
ψi(s)Zi =: Z∗(s),
log r(s) = X(s)β + Z∗(s)
Z ∼ N
(
0,Q(ρ, σ)−1
)
β ∼ N (0, 10I)
σ ∼ PCprior(0.01, 1)
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where X(s) = (X0(s),X1(s), . . . ,Xl(s)) is a row vector of 
spatial covariates and I is the identity matrix. The user-
defined scale of the PC prior of the standard deviation σ 
was chosen such that the variance of the log relative risk 
at any fixed location exceeds 1 with probability 0.01. The 
scale for the range parameter ρ was adjusted so that the 
probability of having range smaller than 60 km is 0.50. 
We used the Integrated Nested Laplace Approximation 
(INLA) to render Bayesian analysis for the above model 
computationally feasible [27, 28].
We computed maps of posterior median (unadjusted or 
adjusted for the covariates) of spatial relative risk (RR, i.e. 
exp{Z(s)} ) compared to national level on a 1× 1 km2 grid. 
We also mapped exceedance probabilities defined as the 
posterior probability, in each grid cell, that RR exceeds 1. 
The fixed effects βi (log-relative-risk per unit increase in 
the covariate) are reported as posterior median of RR, i.e. 
exp{βi} , and 95% credibility intervals (CI). The continu-
ous variables  NO2, ionizing radiation, SEP and years of 
cantonal cancer registration were scaled and thus exp{βi} 
is interpreted as the multiplicative change of the risk at a 
fixed location when the covariate is increased by 1 stand-
ard deviation (SD). They were included as linear terms 
since there was no indication for a more complex model 
(Additional file  1: Figure S9). Henceforth, the model 
adjusted for the aforementioned covariates is referred to 
as the adjusted model, whereas the model without covar-
iates as the unadjusted. Both adjusted and unadjusted 
models were standardised for population, age and year of 
diagnosis by including the expected number of cases as 
an offset in the model (Additional file 1: Text S1, S2).
We also report the percentage of variance explained by 
the selected risk factors by evaluating median and 95% CI 
of the posterior of an extension of Bayesian R2 [29]:
where V (·) denotes the variance over the K  spatial units, 
β is the vector of intercept and covariates and X(s) is the 
ρ ∼ PCprior(0.5, 60)
R2 =
V (X(s)β)
V (X(s)β)+ V (Z(s))
,
design matrix. We calculated R2 for the fully adjusted 
model, a model including all selected covariates except 
years of cantonal cancer registration (we refer to this set 
of covariates as ‘putative risk factors’), and the univari-
able model including only years of cantonal cancer reg-
istration. This allowed us to distinguish spatial variation 
explained purely by the degree of completeness of regis-
tration from variation explained by covariates that might 
reflect aetiological factors (putative risk factors). For 
consistency with the literature, we also fitted the Besag-
York-Mollié (BYM) model using disease counts per 
municipality, for more information see [26, 30, 31] and 
Additional file 1: Text S2
Sensitivity analysis
We ran a sensitivity analysis to examine the robustness of 
the results with respect to different scalings of the penal-
ized complexity priors for the range parameter of the 
latent field [26], with median range fixed at 1, 10, 60, 120 
and 240 km.
Results
Study population
We identified 5969 cases with childhood cancer dur-
ing 1985–2015 in Switzerland. We excluded 22 (0.3%) 
cases without available geocode of residence at diagno-
sis. Of the included 5947 children, 32% (N = 1880) had 
leukemia, 13% (N = 772) lymphoma and 22% (N = 1290) 
a CNS tumor. For the analysis using location at birth we 
first excluded 1194 cases born before 1985 and then 577 
additional cases with no geocode at birth yielding 4198 
cases for the analysis (Table 1). Of the excluded cases for 
this analysis, 342 were born abroad, 114 were born in 
Switzerland but no address was recorded, while for 121 
the country of birth was missing. The age and sex distri-
bution follows similar patterns as in neighbouring coun-
tries (Table 1) [32, 33].
Spatial analysis
We found evidence of spatial variation for all cancers 
combined and CNS tumours at diagnosis, Fig. 1, Table 2 
Table 1 Number of cases and median age at diagnosis for the analysis based on the location at birth and diagnosis
N number of cases, CNS Central Nervous System
Birth Diagnosis
Total N (%) Female N (%) Median age 
at diagnosis
Total N (%) Female N (%) Median age 
at diagnosis
All cancers 4198 (100) 1875 (45) 4.8 5947 (100) 2654 (45) 6.4
Leukaemia 1384 (33) 570 (41) 4.2 1880 (32) 781 (42) 4.9
Lymphoma 459 (11) 161 (35) 10.2 772 (13) 279 (36) 11.5
CNS tumours 902 (21) 421 (47) 6.0 1290 (22) 590 (456) 7.1
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Fig. 1 Maps of the median prosterior of the spatial relative risk for different cancer types during 1985–2015 in Switzerland. The adjusted models are 
models adjusted for predicted ambient  NO2 concentration, predicted dose rate from terrestrial gamma and cosmic radiation, SEP, years of existing 
general cancer registry in the canton, language region and level of urbanisation
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and Additional file  1: Table  S2. For leukaemia and lym-
phoma, the posterior median of the variance hyperpa-
rameter of the Gaussian field ( σ 2 ) was shrunk to 0 or 
values close to 0, indicating small, if any, spatial variation 
(Table 2 and Additional file 1: Table S2).
For all cancers grouped together, the medians of the 
posterior distributions of the unadjusted RR evaluated 
at the centroids of 1× 1 km2 grid cells varied from 0.83 
to 1.13 (min to max) throughout Switzerland, indicat-
ing at most a 13% increase in the risk in certain grid 
cells compared to Switzerland as a whole (Table 2 and 
Fig. 1). The corresponding exceedance probability maps 
show areas, for which the posterior probability of hav-
ing an RR greater than 1 is above 0.80 highlighted in 
light green or yellow (Fig. 2). When we adjusted for the 
selected covariates almost 72% (95% CI 43%, 89%) of 
the observed variation was explained, with the median 
RR after adjustment varying from 0.86 to 1.08 (min to 
max), Fig. 1, Table 2. The putative risk factors explained 
65% (35%, 86%) of the observed variation (Additional 
file 1: Table S3). In the fully adjusted model, the factors 
predicted ambient  NO2 air concentration (RR 1.02; 95% 
CI 0.99–1.06 per 1 SD increase in  NO2), predicted dose 
rate from terrestrial gamma and cosmic radiation (1.08; 
0.99–1.18) duration in years of general cancer regis-
tration in the canton (1.06; 1.03–1.09) were positively 
associated with cancer risk, whereas the association 
with the other covariates was weak (Fig.  3 and Addi-
tional file 1: Table S4).
Childhood leukaemia risks showed smaller spatial 
variation with the median posterior RR per grid cell 
varying from 0.96 to 1.09 on the unadjusted and from 
0.97 to 1.04 on the fully adjusted model, Fig.  1 and 
Table  2. The proportion of spatial variation explained 
by the selected covariates was 81% (58%, 94%), Table 2, 
whereas solely by the selected risk factor 64% (33%, 
84%), Additional file  1: Table  S3. In the fully adjusted 
model, the factors associated with the spatial risk of 
childhood leukaemia were predicted ambient  NO2 air 
concentration exposure (1.05; 0.99–1.11) and duration 
in years of general cancer registration in the canton 
(1.06; 1.01–1.11), Fig. 3 and Additional file 1: Table S4.
A small amount of spatial variation of RR was also 
observed for childhood lymphoma with the median RR 
varying from 0.90 to 1.13 on the unadjusted model and 
0.96 to 1.07 on the adjusted model (Fig. 1 and Table 2). 
About 82% (60%, 94%) of the observed spatial variation in 
the risk could be explained with the selected covariates, 
most of it due to the putative risk factors (Additional 
file  1: Table  S3). In the fully adjusted model, the factor 
contributing most was living in the French speaking part 
of Switzerland with a 1.18 (0.96, 1.44) RR increase com-
pared to living in the German speaking part, Fig. 3 and 
Additional file 1: Table S4.
Among the investigated diagnostic groups, the greatest 
spatial variation of cancer risks was observed for child-
hood CNS tumours. The median posterior grid-specific 
RR varied from 0.82 to 1.23 before adjusting, and from 
0.87 to 1.25 after adjusting for the selected covari-
ates. These covariates explained 64% (31%, 84%) of the 
observed spatial variation, and the putative risk factors 
alone 62% (28%, 92%), Additional file  1: Table  S3 and 
Table 2. The adjusted RR was increased for the predicted 
exposure to background ionising radiation exposure 
(1.17; 0.98–1.40), SEP (1.06; 1.00–1.13) and duration in 
years of general cancer registration in the canton (1.04; 
0.97–1.12). The association of the other covariates was 
weak, Fig. 3 and Additional file 1: Table S4.
Table 2 Median posterior of  the  variance hyperparameter of  the  Gaussian field ( σ 2 ) for  the  unadjusted and  adjusted 
model, median posterior of  variation explained ( V(Z(s)) ) and  median posterior of  grid specific relative risk based 
on residence at diagnosis
CI credibility intervals, RR grid specific relative risk compared to Switzerland as a whole, LGCP log-Gaussian Cox process, CNS Central and Nervous System
a The unadjusted model refers to the models without any covariates
b Adjusted for  NO2, background radiation, years of general cancer registration, linguistic region and degree of urbanicity
c Variation explained by the covariates from the fully adjusted model, defined as R2 = V(X(s)β)
V(X(s)β)+V(Z(s))
 where V(·) denotes the variance over the K  spatial units, β is the 
vector of intercept and covariates, X  the design matrix and Z(s) the Gaussian field. The variation here refers to the fully adjusted model
d Range is defined as [min, max]
LGCPs
All cancers Leukaemia Lymphoma CNS tumours
σ 2  unadjusteda (median, 95% CI) 0.01 (0, 0.02) 0.00 (0, 0.03) 0.01 (0, 0.04) 0.02 (0.01, 0.06)
σ 2  adjustedb (median, 95% CI) 0.01 (0, 0.03) 0.00 (0, 0.01) 0.00 (0, 0.03) 0.02 (0, 0.06)
Variation  explainedc (median; 95% CI) 0.72 (0.43, 0.89) 0.81 (0.58, 0.94) 0.82 (0.60, 0.94) 0.64 (0.31, 0.84)
RR  unadjusteda (median;  ranged) 0.99 (0.83, 1.13) 1.00 (0.96, 1.09) 0.99 (0.9, 1.13) 1.01 (0.82, 1.23)
RR  adjustedb (median;  ranged) 1.02 (0.86, 1.08) 1.00 (0.97, 1.04) 1.00 (0.96, 1.07) 1.00 (0.87, 1.25)
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Fig. 2 Maps of posterior probabilities that the spatial relative risk per grid cell is larger than 1 (exceedance probabilities) for different childhood 
cancers groups during 1985–2015 in Switzerland. The adjusted models are adjusted for predicted ambient  NO2 air concentration, predicted dose 
rate from terrestrial gamma and cosmic radiation, SEP, duration in years of general cancer registration in the canton, language region and level of 
urbanisation
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We also examined the spatial variation of childhood 
cancers using place of birth. The spatial variation of can-
cer risks was generally smaller but the spatial patterns 
were largely consistent with the results for diagnosis 
(Additional file 1: Figures S10–S11 and Tables S3, S5).
We also examined the spatial variation using the BYM 
model. The maps and variation of median posterior RR 
were similar to the ones obtained by LGCPs, Additional 
file 1: Figures S10–S15. The estimates of the fixed effects 
were in the same direction but tended to be somewhat 
weaker than in the LGCP models (Additional file  1: 
Tables S4–S7).
Sensitivity analysis
The resulting maps and effect estimates varied only lit-
tle when using different priors for the hyperparameters, 
Additional file 1: Figures S16–S25.
Post‑hoc analysis
Given the larger spatial variation in the risk of CNS 
tumours we ran several post hoc analyses for this diag-
nostic group. First, we restricted the analysis to place of 
diagnosis for the period of 1995–2015 (n = 968), in which 
the coverage is highest (> 95%). The resulting spatial pat-
tern was closely similar to the main analysis (Additional 
file 1: Figure S26). Second, we wanted to identify if the 
observed variation of CNS tumour was specific to par-
ticular diagnostic subgroups. We reran the analysis for 
place at diagnosis for astrocytoma (IIIb, n = 511 cases), 
intracranial and intraspinal embryonal tumours (IIIc, 
n = 266) and other CNS (IIIa, IIId–f, n = 512), following 
the classification used in our previous analysis of spa-
tial clustering of childhood cancers in Switzerland [17]. 
We found that intracranial and intraspinal embryonal 
tumours showed the highest spatial variation with the 
median posteriors RR varying from 0.74 to 1.59 (min to 
max) in the unadjusted and 0.74 to 1.38 in the adjusted 
Fig. 3 Univariable and fully adjusted regression analysis at time of diagnosis. The fixed effects are summarized using the posterior median of the 
relative risk together with 95% credibility regions. NO2 nitrogen dioxide, CNS Central Nervous System tumours, BR total dose background radiation, 
SEP socio-economic position, YoR years of existing cantonal registry, G German speaking part, F French speaking part, I Italian speaking part, r rural 
areas, s semi-urban areas, u urban areas. Predicted ambient  NO2 air concentration, predicted background ionising radiation, SEP and duration in 
years of general cancer registration in the canton were scaled so that the standard deviations (SD) are 1 and considered as linear effects. Their 
interpretation is a multiplicative increase (or decrease) in the number of observed cases compared to the number of the expected cases per 1 SD 
increase (or decrease) in the covariate. The sd for predicted ambient  NO2 air concentration is 77.7 μg/m
3 × 10, for  predicted background ionising 
radiation 60.2 nSv/h , for SEP 8.7 units and for duration in years of general cancer registration in the canton 11.6 years. The fully-adjusted models are 
models adjusted for predicted ambient   NO2 air concentration, predicted dose rate from terrestrial gamma and cosmic radiation, SEP, duration in 
years of general cancer registration in the canton, language region and level of urbanisation
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model, Additional file 1: Figure S27. However, the areas 
highlighted in Figs. 1, 2 stand out in all CNS subgroups 
Additional file  1: Figures  S27, S28. Lastly, we hypothe-
sized that differences in diagnostic practices between the 
nine SPOG clinics may explain the apparent spatial vari-
ation of CNS tumour risks. We thus constructed a spatial 
covariate reflecting the catchment areas of the different 
SPOG centres. Including an additional random effect to 
adjust for these catchment areas only slightly reduced 
the unexplained spatial variation. The spatial pattern 
of relative risk remained largely unchanged (Additional 
file 1: Text S3 includes the analysis and figures).
Discussion
Main findings
This nationwide study based on precise locations of resi-
dence sheds new light on the spatial variation of child-
hood cancer incidence in Switzerland and the extent to 
which this variation can be explained by environmental 
exposures and other spatial covariates. The spatial vari-
ation of cancer risk was small for childhood leukaemia 
and lymphoma and mostly explained by covariates. That 
of CNS tumours, particularly intracranial and intraspi-
nal embryonal tumours, was larger and persisted after 
adjustment for covariates. Duration of general cancer 
registration in the canton was associated with higher 
observed cancer risk. Other covariates associated with 
cancer incidence included predicted ambient air concen-
tration of  NO2 for all cancers, lymphoma and leukaemia 
and SEP and modelled dose rates from terrestrial gamma 
and cosmic background radiation for CNS tumours and 
all cancers.
Comparison of our study with other spatial analyses 
of childhood cancer risks
Compared to other studies that have investigated the spa-
tial distribution of childhood cancers, our study stands 
out in that it uses precise geocoded place of residence 
and attempts to explain any spatial variation with com-
monly discussed putative environmental risk factors and 
completeness of registration. Our study is comparable 
with studies that performed parametric disease map-
ping, and in the lack of other studies that used LGCPs, 
with the previous studies that investigated the spatial 
variation of childhood leukaemia risks using areal data 
and BYM models in France [10], Yorkshire, UK [9] and 
in Florida, USA [12]. A study in France on acute leukae-
mia reported no evidence of spatial variation in the inci-
dence of acute leukaemia at the département level [10]. A 
study in Yorkshire using data aggregated on the electoral 
ward level reported higher childhood leukaemia risks in 
the less populated county of North Yorkshire [9]. We did 
not observe higher leukaemia risk in less populated areas. 
Our results are in agreement with a study in Florida that 
reported evidence of spatial variation of brain tumours 
for cases 0–19 years old [12].
Other studies examining the spatial distribution of 
childhood cancer have focused on extra-Poisson varia-
tion and spatial clustering [34]. The general picture shows 
mixed results for childhood leukaemia and weak or no 
evidence of spatial clustering of lymphoma and CNS 
tumours [35–37]. In previous studies using the same 
data, we found no evidence of clustering of childhood 
cancers, leukaemia, lymphoma or CNS tumours, but 
weak evidence, consistent with the literature, for Hodg-
kin lymphoma and embryonal CNS tumours [38, 39]. We 
observed a cluster of intracranial and intraspinal CNS 
tumours in the French speaking part of Switzerland con-
sistent with the pattern observed for CNS tumours in the 
present study [38].
Comparison of our study with other studies 
on environmental risk factors of childhood cancer
The observed spatial associations between childhood 
cancer risks and putative risk factors are in broad agree-
ment with other studies that have investigated these 
associations disregarding the spatial context.
Of the included covariates in the current study, pre-
dicted ambient  NO2 air concentration showed the 
strongest spatial association with childhood leukaemia 
risks. There is increasing evidence of a link between 
traffic related air pollution and childhood cancers, in 
particular childhood leukaemia [40]. In recent meta-
analyses associations with leukaemia risks were strongest 
for exposure to benzene and weaker for  NO2 [3]. Using 
partly overlapping data, we reported an increased risk of 
leukaemia among children living less than 100 m from a 
highway [21].
Previous studies investigating childhood cancer risks in 
relation to background ionising radiation showed mixed 
results [22, 41–44]. While two studies reported associa-
tions between childhood leukaemia and gamma radia-
tion [22, 41], others found no evidence of an association 
[42–44]. Using partly overlapping data, we previously 
reported evidence of associations with gamma radiation 
for both childhood leukaemia and CNS tumours [22]. In 
the current study the association was largest for all can-
cers and CNS tumours. The evidence from other studies 
examining the effect of gamma radiation on the risks of 
CNS tumours in children was weak [41, 43].
Our study found weak evidence of a potential associa-
tion between SEP and CNS tumours. Previous studies 
in Switzerland have reported weak association between 
socioeconomic status and childhood leukaemia inci-
dence, but a strong effect for CNS survival [45, 46]. Our 
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results are consistent with a large UK case–control study 
which reported increased risk of CNS tumours in higher 
social classes [47]. A recent study in Spain also reported 
a positive association between risk of CNS tumours and 
socioeconomic status [48]. In contrast, a study in North-
West England [49] and a study from Norway [50] found 
no evidence of an association between CNS tumours and 
measures of socio-economic status.
Strengths and limitations
To the best of our knowledge this is the first study 
attempting to model and explain the spatial distribution 
of childhood cancers using precise locations of residence. 
We used LGCPs, which represent the current state of the 
art for modelling such point data of disease incidence 
and, as we have recently shown, outperform traditional 
methods in identifying high risk areas [17]. These models 
allowed us to incorporate spatial covariates and quantify 
their contribution to explaining the observed spatial vari-
ation. We also tried to disentangle variation attributed to 
registration completeness from variation due to putative 
risk factors. Furthermore, in contrast to previous studies, 
we examined both place of birth and diagnosis. Although 
results were closely similar, this comparison could poten-
tially have revealed differences in time windows of sus-
ceptibility to different risk factors. The population at risk 
was retrieved from national censuses and cases from a 
nationwide registry with high completeness [19]. We 
attempted to correct for potential selection bias due to 
regional differences in case ascertainment by including 
duration of general cancer registration in the canton and, 
in post hoc analysis, SPOG centre catchment areas.
Due to data availability, we could not include all poten-
tial environmental risk factors discussed in the litera-
ture, for instance pesticide exposure. Furthermore, the 
spatial covariates included are subject to measurement 
errors and do not perfectly capture the spatial variation 
of residential exposures. We had little information about 
the magnitude of measurement errors, making it hard 
to propagate it in our modelling framework. Although 
we partly adjusted for differences in registration cover-
age, there may still be differences unaccounted for by our 
analyses. Our analysis is purely spatial and disregards and 
temporal or spatiotemporal variation. In contrast with 
previous work, which focused on spatiotemporal cluster-
ing [51], we focused on identifying spatial patterns that 
remain stable over comparably long time periods. Such 
patterns potentially reflect stationary sources of relevant 
environmental exposures. We implicitly adjusted for the 
national time trends of childhood cancers using a time 
varying offset. But our analysis ignores any temporal 
or spatiotemporal trends of the selected covariates (e.g. 
 NO2). This may have diluted their effects and biased the 
estimated coefficients towards the null. Such bias may 
have particularly affected estimates for traffic related air 
pollution, as  NO2 concentration decreased considerably 
during the study period while other covariates including, 
SEP, urbanisation and background radiation were rela-
tively stable. Potential avenues of future research include 
extending this analysis to incorporate full spatiotemporal 
risk factors and interactions.
Interpretation of findings
Although the overall completeness of SCCR is larger 
than 95% after the mid-90s [19], we found that duration 
of general cancer registration in the canton can influ-
ence the apparent spatial variation of childhood cancers 
based on data from SCCR. This suggests that there are 
regional differences in registration completeness, which 
should be accounted for in future aetiological studies in 
Switzerland.
Our results are suggestive of an environmental aetiol-
ogy for childhood CNS tumours and of aetiological dif-
ferences between their histological subtypes. In post 
hoc analyses, the observed spatial variation was not fully 
explained by differences in cancer registration in the 
early years of the SCCR as it persisted in the more recent 
periods. Neither did differences between SPOG centres, 
for instance in ascertainment practices, explain the spa-
tial variation. Unmeasured environmental risk factors are 
thus a likely explanation of the observed spatial variation. 
Possibly, spatial differences in the prevalence of genetic 
syndromes associated with these tumours might also par-
tially explain the observed variation. In future research, 
there should be increased attention on putative environ-
mental risk factors of CNS tumours, including SEP, back-
ground radiation and pesticide exposure (which was not 
accounted for in our analyses).
Our analysis shows that, locally, risks for childhood 
cancer in Switzerland can deviate from the national level 
by up to 13% (range of RR: 0.83–1.13). These deviations 
tend to be smaller (0.96–1.09) for childhood leukaemia, 
in which case they appear to be largely explained by spa-
tial covariates included in analysis. In contrast, for CNS 
tumours these variations are larger (0.82–1.23) and to a 
lesser extent explained by included covariates. Adjust-
ments for potential regional differences in registration or 
diagnostic practices did materially reduce this variabil-
ity. If indeed this variation was caused by environmen-
tal factors, similar regional variation is to be expected in 
other countries. While our analysis could not identify the 
source of this variation, it does suggest that environmen-
tal factors other than background radiation and traffic 
related pollution is driving geographic variation in child-
hood CNS tumour incidence. Future research should 
therefore focus on investigating the environmental 
Page 11 of 13Konstantinoudis et al. Int J Health Geogr           (2020) 19:15  
aetiology of CNS tumours. Such research could benefit 
from separate analysis of histological subtypes and the 
pooling of data across different studies to increase statis-
tical power.
Conclusion
This study provides evidence of spatial differences in 
the incidence of childhood CNS tumours in Switzerland 
that could be partially explained by variations in socio-
economic factors and natural background radiation. The 
spatial variation of the risks for childhood leukaemia and 
lymphoma was smaller and mostly explained by meas-
ured covariates. Our study provides further support for 
an environmental aetiology for childhood CNS tumours, 
highlighting the need for future studies to distinguish 
between histologic subtypes.
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